APA
Alkader, M. S., Ashoor, M. M. A., Haddad, T. H., Abureesha, I. A., Rheemi, B. M. A., Lutfi, L., Moumani, Y. & AlSoreeky, M. (2023). Pegylated Liposomal Doxorubicin (PLD) in the treatment of metastatic breast cancer in Jordan: Retrospective survival analysis. Scientific Research Journal of Clinical and Medical Sciences, 3(1), None-None.
MLA
Alkader, Mohammad S., et al. "Pegylated Liposomal Doxorubicin (PLD) in the treatment of metastatic breast cancer in Jordan: Retrospective survival analysis." Scientific Research Journal of Clinical and Medical Sciences 3.1 (2023): None-None.
Chicago
Alkader, Mohammad S., Mohammad M. A. Ashoor, Tamer H. Haddad, Ishaq A. Abureesha, Basher M. A. Rheemi, Laith Lutfi, Yazan Moumani and Mohammad AlSoreeky. "Pegylated Liposomal Doxorubicin (PLD) in the treatment of metastatic breast cancer in Jordan: Retrospective survival analysis." Scientific Research Journal of Clinical and Medical Sciences 3, no. 1 (2023): None-None.
Harvard
Alkader, M. S., Ashoor, M. M. A., Haddad, T. H., Abureesha, I. A., Rheemi, B. M. A., Lutfi, L., Moumani, Y. and AlSoreeky, M. (2023) 'Pegylated Liposomal Doxorubicin (PLD) in the treatment of metastatic breast cancer in Jordan: Retrospective survival analysis' Scientific Research Journal of Clinical and Medical Sciences 3(1), pp. None-None.
Vancouver
Alkader MS, Ashoor MMA, Haddad TH, Abureesha IA, Rheemi BMA, Lutfi L, Moumani Y, AlSoreeky M. Pegylated Liposomal Doxorubicin (PLD) in the treatment of metastatic breast cancer in Jordan: Retrospective survival analysis. Scientific Research Journal of Clinical and Medical Sciences. 2023 Jan;3(1):None-None.
Download PDF
Download XML
